Close Menu

Technion - Israel Institute of Technology

The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.

Researchers are developing a nanopore sensing device that relies on restriction enzymes to target specific clinically relevant variants in pathogens. 

Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.

The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus. 

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.